UK Markets closed
  • NIKKEI 225

    28,523.26
    -110.24 (-0.39%)
     
  • HANG SENG

    29,962.47
    +320.19 (+1.08%)
     
  • CRUDE OIL

    53.28
    +0.04 (+0.08%)
     
  • GOLD FUTURES

    1,871.40
    +4.90 (+0.26%)
     
  • DOW

    31,188.38
    +257.86 (+0.83%)
     
  • BTC-GBP

    26,036.04
    +823.99 (+3.27%)
     
  • CMC Crypto 200

    696.42
    -4.19 (-0.60%)
     
  • Nasdaq

    13,457.25
    +260.07 (+1.97%)
     
  • ^FTAS

    3,816.31
    +22.40 (+0.59%)
     

Imperial X Plc - Participation in Private Placement

·2-min read

16 December 2020

Imperial X Plc

(“Imperial X” or the “Company”)

Participation in Private Placement

Imperial X Plc is pleased to announce that is has participated in a private placement undertaken by Imperial Helium Corp. (“Imperial Helium”) a Canadian company which is focused on acquiring and developing helium resources in the western Canadian Sedimentary Basin.

Subject to completion of the proposed acquisitions announced on 28 August 2020, Imperial X will own 450,000 preference shares in Imperial Helium through the acquisition of Cloudbreak Discovery Corp.

Imperial Helium is undertaking a private placement in advance of its proposed admission to a public equity market during the first quarter of 2021. The private placement has to date raised C$493,000 out of a target raise of C$1,000,000 through the issue of convertible debentures with a 10% coupon, maturing 18 months from the date of issuance, converting automatically into common shares of Imperial Helium at the IPO at a 20% discount to the IPO price. Imperial X has subscribed for C$110,000 convertible debentures.

Kyler Hardy, CEO of Imperial X, is a director of Imperial Helium and consequently the subscription is considered to be a Related Party Transaction under the AQSE Growth Market Rules for Issuers.

Kyler Hardy, CEO, commented “The acquisition of the loan notes combined with the preference shares will form a material asset for Imperial X. Helium is a very exciting economic resource with demand increasing for medical, industrial and scientific applications while geopolitically stable supply is scarce. Imperial Helium is well placed to compete in a developing industry with a strong management team, foundational asset and pipeline of potential acquisitions.”

This announcement contains information which, prior to its disclosure, was inside information for the purposes of Article 7 of EU Regulation 596/2014.

The Directors of the Company accept responsibility for the content of this announcement.

For further information please contact:

Imperial X Plc
Kyler Hardy
Tel: +1 250 877 1394
khardy@cronincapital.com

Novum Securities Limited
David Coffman / Lucy Bowden
Tel: +44 (0)207 399 9400

Blytheweigh
Tim Blythe / Alice McLaren / Madeleine Gordon-Foxwell
Tel: +44 (0)207 138 3204